Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::
▍Researchs
:::

Po-Kuei Hsu

Po-Kuei Hsu, M.D., PhD.

Publications

Journal papers

  1. Chein HC, Chen HS, Wu SC, Hsu PK, Liu CY, Wang BY, Shih CH, Liu CC. The prognostic value of metastatic lymph node number and ratio in esophageal squamous cell carcinoma patients with or without neoadjuvant chemoradiation. Eur J Cardiothorac Surg 2016 [Accepted] (correspondence; SCI)
  2. Hwang JY, Chen HS, Hsu PK, Chao YK, Wang BY, Huang CS, Liu CC, Wu SC. A Propensity - Matched Analysis Comparing Survival after Esophagectomy Followed by Adjuvant Chemoradiation to Surgery Alone for Esophageal Squamous Cell Carcinoma. Ann Surg 2015 [Accepted] (correspondence; SCI)
  3. Chen HS, Wu SC, Hsu PK, Huang CS, Liu CC, Wu YC. The Prognostic Impact of Preoperative and Postoperative Chemoradiation in Clinical Stage II and III Esophageal Squamous Cell Carcinomas - A population based study in Taiwan. Medicine 2015;94:e1002 (correspondence; SCI)
  4. Hsu PK, Lin WC, Chang YC, Chan ML, Wang BY, Liu CY, Huang WC, Shih CH, Liu. Multi-Institutional Analysis of Single-Port Video-Assisted Thoracoscopic Anatomic Resection for Primary Lung Cancer. Ann Thorac Surg 2015;99:1739-44. (SCI)
  5. Hsu PK, Chen HS, Wang BY, Wu SC, Liu CY, Shih CH, Liu CC. Hospital type- and volume-outcome relationships in esophageal cancer patients receiving non-surgical treatments. World J Gastroenterol 2015;28:1234-42. (SCI)
  6. Wang BY, Liu CY, Hsu PK, Shih CS, Liu CC. Single-Incision Versus Multiple-Incision Thoracoscopic Lobectomy and Segmentectomy: A Propensity-Matched Analysis. Ann Surg. 2015;261:793-9. (SCI)
  7. Wang BY, Lin PY, Wu SC, Chen HS, Hsu PK, Shih CS, Liu CY, Liu CC, Chen YL. Comparison of Pathologic Stage in Patients Receiving Esophagectomy With and Without Preoperative Chemoradiation Therapy for Esophageal SCC. J Natl Compr Canc Netw. 2014;12:1697-705. (SCI)
  8. Hsu PK, Chen HS, Wu SC, Wang BY, Liu CY, Shih CH, Liu CC. Impact of hospital volume on long-term survival after resection for oesophageal cancer: a population-based study in Taiwan. Eur J Cardiothorac Surg. 2014;46:e127-35. (SCI)
  9. Tseng YC, Hwang JY, Hsu PK, Hsu WH, Pan CC. Mediastinal angiomatosis. Ann Thorac Surg. 2014;983:1116. (correspondence; SCI)
  10. Liu CY, Hsu PK, Huang CS, Sun YH, Wu YC, Hsu WH. Chylothorax Complicating Video-Assisted Thoracoscopic Surgery for Non-small Cell Lung Cancer. World J Surg 2014;38:2875-81. (correspondence; SCI)
  11. Hsu PK, Huang CS, Hsieh CC, Wu YC, Hsu WH. Role of Right Upper Mediastinal Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma Patients after Tri-incisional Esophagectomies. Surgery 2014;156:1269-77. (SCI)
  12. Hsu PK, Hsu WH. Reply to Prognostic Signi?cance of Lymph Node Counts in Operable Esophageal Cancer. Ann Thorac Surg. 2014;97:2229-30. (SCI)
  13. Hsu PK, Huang CS, Wang BY, Wu YC, Hsu WH. Survival Benefits of Postoperative Chemoradiation in Lymph Node-Positive Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 2014;97:1734-41.(SCI)
  14. Hsu PK, Kao HL, Chen HY, Yen CC, Wu YC, Hsu WH, Chou TY. Loss of CRNN Expression is Associated with Advanced Tumor Stage and Poor Survival in Esophageal Squamous Cell Carcinoma Patients. J Thorac Cardiovasc Surg 2014;147:1612-8. (SCI)
  15. Hsieh MS, Hsu PK, Chen PL, Hsu WH. Aorto-oesophageal fistula with upper gastrointestinal tract intramural haematoma in an oesophageal cancer patient. Eur J Cardiothorac Surg. 2014;45:584. (correspondence, SCI)
  16. Huang CS, Chen PT, Cheng SH, Chen CK, Hsu PK, Hsieh CC, Shih CC, Hsu WH. Relative contraindications for percutaneous tracheostomy: from the surgeons' perspective. Surg Today. 2014;44:107-14. (SCI)
  17. Hsu PK, Huang CS, Wu YC, Chou TY, Hsu WH. Open versus Thoracoscopic Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma. World J Surg. 2014;38:402-9. (SCI)
  18. Hsu PK, Chen HY, Yeh YC, Yen CC, Wu YC, Hsu CP, Hsu WH, Chou TY. TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma. J Gastroenterol. 2014;49:1231-40. (SCI)
  19. Duann CW, Hung JJ, Hsu PK, Huang CS, Hsieh CC, Hsu HS, Wu YC, Hsu WH. Surgical outcomes in lung cancer presenting as ground-glass opacities of 3 cm or less: A review of 5 years' experience. J Chin Med Assoc. 2013;76:693-7. (SCI)
  20. Yu YC, Hsu PK, Yeh YC, Huang CS, Hsieh CC, Chou TY, Hsu HS, Wu YC, Huang BS, Hsu WH. Surgical Results of Synchronous Multiple Primary Lung Cancers: Similar to the Stage-Matched Solitary Primary Lung Cancers? Ann Thorac Surg. 2013;96:1966-74. (SCI)
  21. Hsu PK, Huang CS, Wang BY, Wu YC, Chou TY, Hsu WH. The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients after Transthoracic Resection. Ann Thorac Surg 2013;96:995-1001. (SCI)
  22. Hsu PK, Chien LI, Huang CS, Hsieh CC, Wu YC, Hsu WH, Chou TY. Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all? Interact Cardiovasc Thorac Surg. 2013;17:460-6. (SCI)
  23. Wang BY, Liu CY, Lin CH, Hsu PK, Hsu WH, Wu YC, Cheng CY. Endoscopic Tumor Length Is an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2012;19:2149-58. (SCI)
  24. Hsu PK, Lin KH, Wang SJ, Huang CS, Wu YC, Hsu WH. Preoperative PET/CT predicts advanced lymph node metastasis in esophageal squamous cell carcinoma patients. World J Surg. 2011;35:1321-6. (SCI)
  25. Hsu PK, Wang BY, Huang CS, Wu YC, Hsu WH. Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection. J Gastrointest Surg. 2011;15:558-65. (SCI)
  26. Hsu PK, Wang BY, Chou TY, Huang CS, Wu YC, Hsu WH. The total number of resected lymph node is not a prognostic factor for recurrence in esophageal squamous cell carcinoma patients undergone transthoracic esophagectomy. J Surg Oncol. 2011;103:416-20. (SCI)
  27. Wang BY, Goan YG, Hsu PK, Hsu WH, Wu YC. Tumor length as a prognostic factor in esophageal squamous cell carcinoma. Ann Thorac Surg. 2011;91:887-93. (SCI)
  28. Wang BY, Wu YC, Hung JJ, Hsu PK, Hsieh CC, Hunag CC, Hsu WH. Prognosis of non-small cell lung cancer with unexpected pleural spread at thoracotomy. J Surg Res 2011;169:e1-5. (SCI)
  29. Hsu PK, Wu YC, Chou TY, Huang CS, Hsu WH. Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma. Ann Thorac Surg. 2010;89:1024-31. (SCI)
  30. Hsu PK, Shai SE, Wang J, Hsu CP. Esophageal metastasis from occult lung cancer. J Chin Med Assoc. 2010;73:327-30. (SCI)
  31. Liu CC, Hsu PK, Lin HJ, Hsu WH. Pulmonary amyloidosis presenting as a solitary pulmonary nodule in a patient of Sjogren`s syndrome. Thorac Med 2010;25:258-62.
  32. Li AF, Hsu PK, Tzao C, Wang YC, Hung IC, Huang MH, Hsu HS. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus. Ann Surg Oncol. 2009;16:2486-93. (co-first author) (SCI)
  33. Wu YC, Hsu PK, Su KC, Liu LY, Tsai CC, Tsai SH, Hsu WH, Lee YC, Perng DW. Bile acid aspiration in suspected ventilator-associated pneumonia. Chest. 2009;136:118-24. (SCI)
  34. Hsu WH, Hsu PK, Wang SJ, Lin KH, Huang CS, Hsieh CC, Wu YC. Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma. Ann Thorac Surg. 2009;87:1564-8. (SCI)
  35. Hsu WH, Hsu PK, Hsieh CC, Huang CS, Wu YC. The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer. J Gastrointest Surg. 2009;13:1913-20. (SCI)
  36. Cheng TH, Hsu PK, Li AF, Hung IC, Huang MH, Hsu HS. Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2009;135:1577-82. (SCI)
  37. Hsu PK, Cheng HF, Yeh YC, Wu YC, Hsu WH. Pulmonary sclerosing haemangioma mimicking lung cancer on PET scan. Respirology. 2009 ;14:903-6. (SCI)
  38. Hsu PK, Hsu WH, Wu YC. Central large pulmonary arteriovenous malformation with aneurysmal dilatation. Thorac Cardiovasc Surg. 2009;57:434-6. (SCI)
  39. Hsu PK, Li AF, Wang YC, Hsieh CC, Huang MH, Hsu WH, Hsu HS. Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus. J Thorac Cardiovasc Surg. 2008;135:1029-35. (SCI)
  40. Liu CC, Wang HW, Li FY, Hsu PK, Huang MH, Hsu WH, Hsu HS, Wang LS. Solitary fibrous tumors of the pleura: clinicopathological characteristics, immunohistochemical profiles, and surgical outcomes with long-term follow-up. Thorac Cardiovasc Surg. 2008;56:291-7. (SCI)
  41. Hsu PK, Li AF, Hsu WH. Simultaneous thoracotomy and laparotomy for small cell carcinoma of oesophagogastric junction. ANZ J Surg. 2008;78:723-4. (SCI)
  42. Hsu PK, Hsu WH. Chest wall mass caused by salmonella enteritidis - a pitfall of PET imaging interpretation.Thorac Cardiovasc Surg. 2008;56:239-40. (SCI)
  43. Hsu PK, Huang HC, Hsieh CC, Hsu HS, Wu YC, Huang MH, Hsu WH. Effect of formalin fixation on tumor size determination in stage I non-small cell lung cancer. Ann Thorac Surg. 2007;84:1825-9. (SCI)
  44. Liu CC, Hsu PK, Huang WC, Huang MH, Hsu HS. Two-layer method (UW solution/perfluorochemical plus O2) for lung preservation in rat lung transplantation. Transplant Proc. 2007;39:3019-23. (SCI)
  45. Hsu PK, Hsu HS, Li AF, Wang LS, Huang BS, Huang MH, Hsu WH. Non-Hodgkin's lymphoma presenting as a large chest wall mass.Ann Thorac Surg. 2006;81:1214-8. (SCI)
  46. Hsu PK, Hsu HS, Lee HC, Hsieh CC, Wu YC, Wang LS, Huang BS, Hsu WH, Huang MH. Management of primary chest wall tumors: 14 years' clinical experience. J Chin Med Assoc. 2006;69:377-82. (SCI)
  47. Lin YT, Hsu PK, Hsu HS, Huang CS, Wang LS, Huang BS, Hsu WH, Huang MH. En bloc resection for lung cancer with chest wall invasion. J Chin Med Assoc. 2006;69:157-61. (SCI)
  48. Hsu PK, Wang CY, Huang MS. Chest tube malpositioning-related hemothorax and intra-abdominal bleeding — A case report. Thorac Med 2006; 21: 524-528.

 

Conference papers

  1. Primary chest wall tumors ~14 years clinical experience~. 2005 Annual Meeting of Taiwan Surgical Association, Taipei, Taiwan
  2. The protein expression of p53/MDM2/p14arf pathway in squamous cell carcinoma of esophagus and its prognostic significance. 2006 Annual Meeting of Taiwan Surgical Association, Taipei, Taiwan
  3. Malposition of chest tube related hemothorax and intraabdominal bleeding: A case report. 2006 Annual Meeting of Taiwan Surgical Association, Taipei, Taiwan
  4. The effect of formalin fixation on tumor size determination in stage I non-small cell lung cancer. 2007 Annual Meeting of Taiwan Surgical Association, Taipei, Taiwan
  5. Reduced membranous β-catenin expression is associated with metastasis and poor prognosis in squamous cell carcinoma of esophagus. 2007 Annual Meeting of Taiwan Surgical Association, Taipei, Taiwan
  6. Reduced axin protein expression is associated with a poor prognosis in patients of squamous cell carcinoma of esophagus. 2007 Annual Meeting of Taiwan Association of Thoracic and Cardiovascular Surgery, Taipei, Taiwan
  7. Solitary nodular pulmonary amyloidosis mimicking lung cancer in a patient with Sjogren`s syndrome. 2008 18th WSCTS World Congress, Kos-island, Greece
  8. Centrally-located pulmonary sclerosing hemangioma mimicking lung cancer on FDG-PET scan. 18th WSCTS World Congress, Kos-island, Greece
  9. The number and ratio of metastatic lymph node, but not total number of resected lymph node, predict survival in esophageal cancer. 2009 17th Annual Meeting of Asian Society for Cardiovascular and Thoracic Surgery, Taipei, Taiwan
  10. Positron emission tomography–computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma. 2009 17th Annual Meeting of Asian Society for Cardiovascular and Thoracic Surgery, Taipei, Taiwan
  11. The number and ratio of metastatic lymph node, but not total number of resected lymph node, predict survival in esophageal cancer. 2009 Digestive Disease Week, Chicago, U.S.A.
  12. Esophageal cancer “N” stage classification and its correlation with PET/CT findings. 2010 Annual Meeting of Taiwan Surgical Association, Taipei, Taiwan
  13. Comparison of the 6th and 7th editions of the American Joint Committee on Cancer Tumor-Node-Metastasis staging system in patients with resected esophageal carcinoma. 2010 Annual Meeting of Taiwan Association of Thoracic and Cardiovascular Surgery, Taipei, Taiwan
  14. Expression of AURKA/TPX2 in Esophageal Squamous Cell Carcinoma. 2011 Annual Meeting of Taiwan Association of Thoracic and Cardiovascular Surgery, Taipei, Taiwan
  15. Expression of Aurora-A/TPX2 in Stage I Lung Adenocarcinoma Patients. 2012 Annual Meeting of Taiwan Surgical Association, Taipei, Taiwan
  16. TPX2 overexpression is associated with tumorigenesis and patient outcome of esophageal squamous cell carcinoma. 2012 American Association for Cancer Research Annual Meeting, Chicago, U.S.A.
  17. Thoracoscopic debridement of aortic aneurysm sac. 2013 11th Asia Pacific Congress of Endoscopic and Laparoscopic Surgery (ELSA 2013).
  18. Initial Experience of Single-Port Thoracoscopic Major Lung Resection and Radical Lymphadenectomy for Cancer. 2013 Annual Meeting of Taiwan Society of Pulmonary and Critical Care Medicine, Taipei, Taiwan.
  19. Comparison of survival among neoadjuvant chemoradiation responders, nonresponders and patients receiving primary resection for locally advanced esophageal squamous cell carcinoma. 2014 Annual Meeting of Taiwan Surgical Association, Taipei, Taiwan
  20. Role of superior mediastinal lymph node metastasis in esophageal squamous cell carcinoma. 2014 Annual Meeting of Taiwan Surgical Association, Taipei, Taiwan
  21. Does Hospital Volume Affect Long-Term Survival in Esophageal Cancer Patients? A Population-based Study in Taiwan. 2014 22nd European Conference on General Thoracic Surgery, Copenhagen, Denmark.
  22. Clinical significance of epidermal differentiation complex gene expression in esophageal squamous cell carcinoma. 2014 World Congress of International Society for Diseases of the Esophagus, Vancouver, Canada.
  23. Single-Port Video-Assisted Thoracoscopic Lung Resection – A Multi-institutional Series of 208 Cases. 2015 STS 51st Annual Meeting, San Diego, U.S.A.

 

Awards

  1. 2009 Poster of Distinction. Digestive Disease Week, Chicago, U.S.A.
  2. 2010 Young Investigator Award. Annual Meeting of Taiwan Association of Thoracic and Cardiovascular Surgery.

     

Research Grants

  1. Grant from Veterans General Hospital (V96A-015), 2007. Management of Primary Chest Wall Tumors: 14 years’ Clinical Experience.
  2. Grant from Memorial K.S.Lu Lung Cancer Foundation, 2009. Simultaneous Osteosarcoma Lung Metastasis and Second Primary Lung Cancer in Young Age Patient – Genetic Analysis.
  3. Grant from Memorial K.S.Lu Lung Cancer Foundation, 2010. Correlation between PET/CT findings and the 6th and 7th edition of AJCC TNM staging system.
  4. Grant from Memorial K.S.Lu Lung Cancer Foundation, 2011. Exploring gene expression changes during esophageal squamous cell carcinoma tumorigenesis with high throughput method.
  5. Grant from Memorial K.S.Lu Lung Cancer Foundation, 2012. Prediction of neoadjuvant chemoradiation response in esophageal squamous cell carcinoma.
  6. Grant from Veterans General Hospital (V102B-049), 2013. Genome-wide  gene  expression  profiling  of  esophageal  squamous  cell  carcinoma  by  microarray analysis.
  7. Grant from National Science Council (NSC 102-2314-B-075-081), 2013. Biomarkers predicting neoadjuvant chemoradiation response in esophageal squamous cell carcinoma.
  8. Grant from Memorial K.S.Lu Lung Cancer Foundation, 2013. The role of epidermal differentiation complex gene expression in esophageal squamous cell carcinoma.
  9. Grant from Veterans General Hospital (V103B-008), 2014. Biomarkers predicting early recurrence and poor prognosis in node-negative esophageal squamous cell carcinoma.
  10. Grant from Memorial K.S.Lu Lung Cancer Foundation, 2014.The Clinical Significance of CYFRA21-1 in Esophageal Squamous Cell Carcinoma.
  11. Grant from Veterans General Hospital (V104B-0022), 2014. Predictive markers for outcome after esophagectomy and adjuvant chemoradiation for cancer.
  12. Grant from National Science Council (NSC 104-2314-B-075 -029), 2015. Application of Next-Generation Sequencing to Identify Biomarkers Predicting Patient Survival and Adjuvant Chemoradiation Response in Esophageal Squamous Cell Carcinoma.
  13. Grant from Veterans General Hospital (V105B-0022), 2015. Validation of deep-sequencing technique derived biomarkers which may predict neoadjuvant chemoradiation response in esophageal cancer
 

Last Modified：

回到最上